What is the market doing?
What the tape says about TEVA
Teva Pharmaceutical Industries Limited is +103% over the past year while the S&P 500 is +20%: 83 points ahead of the market.
+103%
1-year return · S&P 500 +20%
- vs 200-day average
- +15%
vs 200-day average · a clear uptrend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 3.8%
Below its 52-week high
Details›
- Last close2026-09-08
- $36.67
- 1 monthS&P 500 −0.30%
- +5.3%
- 1 yearS&P 500 +20%
- +103%
- 5 yearsS&P 500 +85%
- +260%
- vs 50-day average$34.42
- +6.6%
- 52-week high
- $38.10
- 52-week low
- $17.56
- Annualised volatility
- 44%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$9.6M
| Year | Return |
|---|---|
| 2026 (year to date) | +17% |
| 2025 | +42% |
| 2024 | +111% |
| 2023 | +14% |
| 2022 | +14% |
| 2021 | −17% |
| 2020 | −1.5% |
| 2019 | −36% |
| 2018 | −19% |
| 2017 | −46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 8 of 10 | +8.3% |
| Feb | 10 | 3 of 10 | −2.4% |
| Mar | 10 | 3 of 10 | −4.4% |
| Apr | 10 | 4 of 10 | +2.1% |
| May | 10 | 6 of 10 | −0.52% |
| Jun | 10 | 4 of 10 | +1.2% |
| Jul | 11 | 4 of 11 | +0.79% |
| Aug | 11 | 4 of 11 | −3.3% |
| Sep | 11 | 5 of 11 | −0.77% |
| Oct | 10 | 4 of 10 | −3.3% |
| Nov | 10 | 6 of 10 | +7.0% |
| Dec | 10 | 6 of 10 | +4.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #5 of 29 by Smart Score